Remove how-to-patent-in-europe-epo
article thumbnail

US Supreme Court decision in Amgen v Sanofi: The European Perspective

The IPKat

The US Supreme Court recently ruled in the high profile Amgen versus Sanofi patent dispute. 2021 ), the Supreme Court found Amgen's function and epitope defined PCSK9 antibody patents to lack enablement ( Amgen Inc v Sanofi, No. The US Supreme Court was keen to stress that its reasoning did not alter the law on enablement.

article thumbnail

USPTO call for comments: Impact of AI on patentability

The IPKat

The USPTO has issued a request for comments regarding the impact of AI on patentability. The USPTO specifically calls for views on how the proliferation of AI could affect evaluations of patentability, including what qualifies as prior art and the capabilities of the person skilled in the art. Comments are due by 29 June 2024.

Patent 62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Relook at Business Methods in light of Madras High Court’s Decision in Priya Randolph v. Deputy Controller 

SpicyIP

Deputy Controller , Madras High court rejected the contention that the subject invention was excluded for being business method. The findings of this short judgement have possible significant implications on the jurisprudence regarding 3(k) and business methods in the Patent Act. 3(k) of the Patent Act and thereby excluded.

article thumbnail

Benefits and pitfalls of functional patent claims (and why the UK is out of step with the EPO on claim construction): Astellas v Teva [2023] EWHC 2571 (Pat)

The IPKat

In the recent UK decision Astellas v Teva [2023] EWHC 2571 (Pat) Mr Justice Mellor in the High Court considered sufficiency, inventive step and infringement of Astellas' formulation patent for mirabegron. The decision also deviates from EPO practice on sufficiency and the inventive step of selection inventions.

article thumbnail

EPO Appeal Board Affirms Only Humans Can Be Inventors

Intepat

It is still rethinking how to approach and solve challenges in a wide range of sectors. Artificial intelligence (“AI”) advancements in this Fourth Industrial Revolution period have resulted in AI capable of developing innovative and inventive inventions. BACKGROUND.

article thumbnail

“The Reasonable Robot” tackles AI’s impact on the economy, intellectual property rights, and more

IPilogue

Ryan Abbott is Professor of Law and Health Sciences at the University of Surrey School of Law and Adjunct Assistant Professor of Medicine at the David Geffen School of Medicine at UCLA. It finds that laws written with people in mind often give an unintentional preference to either human or AI activity.

article thumbnail

Around the IP Blogs

The IPKat

with specific examples of how well-known companies are filing trade mark applications related to the use of tokens in virtual environments. with specific examples of how well-known companies are filing trade mark applications related to the use of tokens in virtual environments. Meanwhile, in Japan, Apple Inc.